Modular Medical, Inc.
For the period ended Mar 31, 2026. Filed Jun 29, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Jun 29, 2026
MODD$1.85+39.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. EXHIBITS
| (a) | Consolidated Financial Statements |
The following documents are filed as part of this Report:
| ● | Consolidated Financial Statements and Report of Independent Registered Public Accounting Firm, all of which are set forth are set forth under Part II, Item 8 of this Report. |
| (b) | Financial Statement Schedules |
Financial statement schedules may omitted because they are not applicable, not required, or because the required information is included in the consolidated financial statements or notes thereto.
| (c) | Exhibits: |
Required exhibits are incorporated by reference or are filed with this Report.
| Exhibit · Reference · Filed or Furnished | |||||
|---|---|---|---|---|---|
| Number | Exhibit Description | Form | Exhibit | Filing Date | Herewith |
| 1.1** | Sales Agreement, dated as of November 22, 2023, between Modular Medical, Inc. and Leerink Partners LLC | 8-K | 1.1 | 11/22/2023 | |
| 1.2 | Underwriting Agreement dated as of December 10, 2025 between Modular Medical, Inc. and Newbridge Securities Corp. | 8-K | 1.1 | 12/11/2025 | |
| 1.3 | Form of Placement Agency Agreement | S-1 | 1.1 | 02/27/2026 | |
| 2.1** | Reorganization and Share Exchange Agreement dated as of July 24, 2017, by and among Modular Medical, Inc., Quasuras, Inc., Paul DiPerna and the other stockholders of Quasuras, Inc. | 8-K | 2.1 | 07/28/2017 | |
| 2.2 | Addendum No. 1 to Reorganization and Share Exchange Agreement dated as of July 24, 2017, by and among Modular Medical, Inc., Quasuras, Inc., Paul DiPerna and the other Stockholders of Quasuras, Inc. dated May 3, 2021 | 8-K | 2.2 | 05/12/2021 | |
| 3.1 | Third Amended and Restated Articles of Incorporation, as filed with the Secretary of State of Nevada on June 27, 2017 | 8-K | 3.1 | 06/29/2017 | |
| 3.2 | Certificate of Amendment to the Amended and Restated Articles of Incorporation of Modular Medical, Inc., filed with the Secretary of State of the State of Nevada on November 24, 2021 | 8-K | 3.1 | 12/01/2021 | |
| 3.3 | Certificate of Amendment to the Amended and Restated Articles of Incorporation of Modular Medical, Inc., filed with the Secretary of State of the State of Nevada on February 15, 2024 | 8-K | 3.1 | 02/15/2024 | |
| 3.4 | Certificate of Amendment to the Amended and Restated Articles of Incorporation of Modular Medical, Inc., filed with the Secretary of State of the State of Nevada on January 23, 2026 | 8-K | 3.1 | 01/23/2026 | |
| 3.5 | Certificate of Amendment to the Amended and Restated Articles of Incorporation of Modular Medical, Inc., filed with the Secretary of State of the State of Nevada on March 30, 2026 | 8-K | 03/31/2026 | ||
| 3.6 | Amended Bylaws | 10-SB | 3.2 | 03/08/2002 | |
| 4.1* | Amended and Restated 2017 Equity Incentive Plan, as amended | X | |||
| 4.2 | Form of Warrant to Purchase Common Stock dated February 14, 2022 | 8-K | 4.1 | 02/14/2022 | |
| 4.3 | Form of Pre-Funded Warrant to Purchase Common Stock dated May 2, 2022 | 8-K | 4.1 | 05/05/2022 | |
| 4.4 | Form of Private Placement Warrant dated May 2, 2022 | 8-K | 4.2 | 05/05/2022 | |
| 4.5 | Form of Investor Warrant dated May 2, 2022 | S-1/A | 4.5 | 05/05/2023 | |
| 4.6 | Form of Underwriter’s Warrant dated May 2, 2022 | S-1/A | 4.6 | 05/05/2023 | |
| 4.7 | Description of Securities of Modular Medical, Inc. | 10-K | 4.7 | 06/26/2023 | |
| 4.8** | Underwriting Agreement, dated as of November 21, 2024, between Modular Medical, Inc. and Titan Partners Group LLC | 8-K | 1.1 | 11/25/2024 | |
| 4.9 | Form of Underwriter Warrant dated November 25, 2024 | 8-K | 4.1 | 11/25/2024 | |
| 4.10 | Form of Investor Common Stock Purchase Warrant dated March 26, 2025 | 8-K | 4.1 | 03/26/2025 | |
| 4.11 | Form of Placement Agent Warrant dated March 26, 2025 | 8-K | 4.2 | 03/26/2025 | |
| 4.12 | Form of Common Stock Purchase Warrant | 8-K | 4.1 | 09/23/2025 | |
| 4.13 | Form of Warrant | 8-K | 4.1 | 12/11/2025 | |
| 4.14 | Form of Underwriter Warrant | 8-K | 4.2 | 12/11/2025 | |
| 4.15 | Promissory Note dated February 23, 2026 | 8-K | 10.27 | 02/24/2026 | |
| Exhibit · Reference · Filed or Furnished | ||||
|---|---|---|---|---|
| Number · Exhibit Description · Form · Exhibit · Filing Date · Herewith | ||||
| 4.16 | Form of Common Warrant | S-1 | 4.14 | 02/27/2026 |
| 4.17 | Form of Pre-funded Warrant | S-1 | 4.15 | 02/27/2026 |
| 10.1* | Employment Agreement dated August 1, 2018, by and between Modular Medical, Inc. and Paul DiPerna | S-1 | 10.4 | 06/27/2019 |
| 10.2 | Intellectual Property Assignment Agreement dated July 24, 2017, by and between Modular Medical, Inc., Quasuras, Inc. and Paul DiPerna | 8-K | 10.3 | 07/28/2017 |
| 10.3* | Technology Royalty Agreement dated as of July 24, 2017, by and between Modular Medical, Inc., Quasuras, Inc. and Paul DiPerna | 8-K | 10.4 | 07/28/2017 |
| 10.4 | Standard Industrial/Commercial Agreement between Modular Medical, Inc. and Michael Summers dated January 5, 2023 | S-1 | 10.28 | 04/24/2023 |
| 10.5* | Form of Indemnification Agreement between Modular Medical, Inc. and each of its directors and officers used from January 23, 2020 | 10-Q | 10.15 | 02/13/2020 |
| 10.6* | Form of Notice of Stock Option Grant and Stock Option Agreement under the Amended and Restated 2017 Equity Incentive Plan, as amended | 10-Q | 10.16 | 02/13/2020 |
| 10.7* | First Amendment to the Employment Agreement between Modular Medical, Inc. and Paul DiPerna effective as of May 12, 2020 | 8-K | 10.18 | 05/27/2020 |
| 10.8* | Second Amendment to Employment Agreement between Modular Medical, Inc. and Paul DiPerna effective as of July 1, 2020 | 10-Q | 10.20 | 08/12/2020 |
| 10.9* | Third Amendment to Employment Agreement between Modular Medical, Inc. and Paul DiPerna effective as of April 8, 2024 | 8-K | 10.1 | 04/10/2024 |
| 10.10 | Form of Convertible Promissory Note issued in the 2021 Private Placement | 8-K | 10.21 | 05/12/2021 |
| 10.11 | Form of Common Stock Purchase Warrant issued in the 2021 Private Placement | 8-K | 10.22 | 05/12/2021 |
| 10.12 | Warrant Agency Agreement between Modular Medical, Inc. and Colonial Stock Transfer Company, Inc. dated February 14, 2022 | 8-K | 10.1 | 02/14/2022 |
| 10.13 | Form of Warrant Omnibus Amendment Agreement | S-1/A | 10.31 | 02/07/2022 |
| 10.14* | Severance and Release Agreement between Modular Medical, Inc. and Ellen O’Connor Vos dated February 23, 2022 | S-1 | 10.33 | 07/06/2022 |
| 10.15* | Offer Letter Agreement between Modular Medical, Inc. and Kevin Schmid dated July 13, 2022 | 8-K | 10.1 | 07/26/2022 |
| 10.16* | Form of Notice of Grant of Restricted Stock Unit Award and Agreement under the Amended and Restated Modular Medical, Inc. 2017 Equity Incentive Plan, as amended | 10-Q | 4.11 | 08/14/2023 |
| 10.17 | Form of Warrant Agency Agreement | S-1/A | 10.29 | 05/05/2023 |
| 10.18* | Modular Medical, Inc. Two-Part FDA Submission and Clearance Milestone Bonus Program | 8-K | 10.1 | 10/05/2023 |
| 10.19** | Form of Securities Purchase Agreement dated March 26, 2025 | 8-K | 10.1 | 03/26/2025 |
| 10.20** | Form of Subscription Agreement dated March 25, 2025 | 8-K | 10.2 | 03/26/2025 |
| 10.21 | Form of 2023 Inducement Letter | 8-K | 10.1 | 09/23/2025 |
| 10.22 | Form of 2025 Inducement Letter | 8-K | 10.2 | 09/23/2025 |
| 10.23** | Form of Securities Purchase Agreement | S-1 | 10.13 | 02/27/2026 |
| 10.24 | Form of Warrant Agency Agreement | S-1 | 10.14 | 02/27/2026 |
| 14.1 | Code of Business Conduct and Ethics | 10-K | 14.1 | 06/20/2025 |
| 19.1 | Insider Trading Compliance Program | 10-K | 19.1 | 06/20/2025 |
| Exhibit · Reference · Filed or Furnished | |||||
|---|---|---|---|---|---|
| Number | Exhibit Description | Form | Exhibit | Filing Date | Herewith |
| 21.1 · Sole Subsidiary of Modular Medical, Inc. (as disclosed in the Notes to Consolidated Financial Statements as of March 31, 2026 in Item 8 of this Report) · X | |||||
| 23.1 · Consent of Independent Registered Public Accounting Firm · X | |||||
| 24.1 · Power of Attorney (see signature page of this Report) · X | |||||
| 31.1 · Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 · X | |||||
| 31.2 · Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 · X | |||||
| 32.1 · Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 · X | |||||
| 97.1 | Compensation Recovery Policy | 10-K | 97.1 | 06/21/2024 | |
| 101.INS | Inline XBRL Instance Document. | X | |||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Linkbase Document. | X | |||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | X | |||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | X | |||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. | X | |||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase X Document. | X | |||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). | X | |||
| * | Indicates a management contract or compensatory plan or arrangement. |
| ** | Certain schedules, exhibits and similar attachments have been omitted pursuant to Item 601(a)(5) of Regulation S-K. Modular Medical, Inc. hereby undertakes to furnish copies of such omitted materials supplementally upon request by the SEC. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.